{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:45:39Z","timestamp":1767649539611},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.antiviral.2009.11.003","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T05:29:48Z","timestamp":1258003788000},"page":"366-372","source":"Crossref","is-referenced-by-count":10,"title":["Avoiding drug-resistance development by novel approach of combining anti-enteroviral substances against coxsackievirus B1 infection in mice"],"prefix":"10.1016","volume":"85","author":[{"given":"Ralitsa","family":"Vassileva-Pencheva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel S.","family":"Galabov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2009.11.003_bib1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2174\/138161206776361129","article-title":"Current status of anti-picornavirus therapies","volume":"12","author":"Barnard","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.antiviral.2009.11.003_bib2","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.48.5.1766-1772.2004","article-title":"In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity","volume":"48","author":"Barnard","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.11.003_bib3","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1128\/JVI.71.11.8482-8489.1997","article-title":"Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C","volume":"71","author":"Barton","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.11.003_bib4","series-title":"ViroPharma Press Releases","author":"Beer","year":"2002"},{"key":"10.1016\/j.antiviral.2009.11.003_bib5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrmicro1769","article-title":"Vaccination against polio should not be stopped","volume":"5","author":"Chumakov","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2009.11.003_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/infdis\/141.1.87","article-title":"Inhibition of rhinovirus replication in organ culture by a potential antiviral drug","volume":"141","author":"DeLong","year":"1980","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.11.003_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/med.20125","article-title":"Selective inhibitors of picornavirus replication","volume":"28","author":"De Palma","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2009.11.003_bib8","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1021\/jm00150a025","article-title":"[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating","volume":"28","author":"Diana","year":"1985","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2009.11.003_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-540-75546-3_1","article-title":"Coxsackieviruses and quasispecies theory: evolution of enteroviruses","volume":"323","author":"Domingo","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2009.11.003_bib10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.143.6.1367","article-title":"Successful treatment of enterovirus-infected mice by 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine","volume":"143","author":"Eggers","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2009.11.003_bib11","first-page":"211","article-title":"Sequence space and quasispecies distribution","volume":"vol. 3","author":"Eigen","year":"1988"},{"key":"10.1016\/j.antiviral.2009.11.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1679\/aohc1950.40.Supplement_1","article-title":"Concept of paraneurons","volume":"40","author":"Fujita","year":"1977","journal-title":"Arch. Histol. Jpn."},{"key":"10.1016\/j.antiviral.2009.11.003_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1679\/aohc.52.Suppl_1","article-title":"Present status of paraneuron concept","volume":"52","author":"Fujita","year":"1989","journal-title":"Arch. Histol. Cytol."},{"key":"10.1016\/j.antiviral.2009.11.003_bib14","series-title":"The Paraneuron","author":"Fujita","year":"1988"},{"key":"10.1016\/j.antiviral.2009.11.003_bib15","first-page":"1863","article-title":"Thiourea derivatives as specific inhibitors of picornaviruses","volume":"29","author":"Galabov","year":"1979","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.antiviral.2009.11.003_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.5.1.1","article-title":"Antiviral activity of N-phenyl-N\u2032-aryl- or alkylthiourea derivatives in Coxsackie virus infections in mice","volume":"5","author":"Galabov","year":"1974","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.11.003_bib17","first-page":"291","article-title":"Inhibitory effect of N-phenyl-N\u2032-3-hydroxyphenylthiourea (PTU-23) on the reproduction of encephalomyocarditis virus in Krebs-II cells","volume":"254","author":"Galabov","year":"1983","journal-title":"Zentralbl. Bacteriol. Microbiol. Hyg. A"},{"key":"10.1016\/j.antiviral.2009.11.003_bib18","first-page":"306","article-title":"Effect of N-phenyl-N\u2032-3-hydroxyphenylthiourea (PTU-23) on the protein synthesis in Krebs-II cells infected with encephalomyocarditis virus","volume":"254","author":"Galabov","year":"1983","journal-title":"Zentralbl. Bacteriol. Microbiol. Hyg. A"},{"key":"10.1016\/j.antiviral.2009.11.003_bib19","doi-asserted-by":"crossref","first-page":"14730","DOI":"10.1073\/pnas.96.26.14730","article-title":"Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16","volume":"96","author":"Hadfield","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2009.11.003_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/AAC.39.2.290","article-title":"Intranasal pirodavir (R77,975) treatment of rhinovirus colds","volume":"39","author":"Hayden","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.11.003_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3181\/00379727-107-26560","article-title":"Plaque-inhibition tests for detection of specific inhibitors of DNA containing viruses","volume":"107","author":"Herrmann","year":"1961","journal-title":"Proc. Soc. Exp. Biol."},{"key":"10.1016\/j.antiviral.2009.11.003_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0166-3542(82)90003-1","article-title":"Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles","volume":"2","author":"Herrmann","year":"1982","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.11.003_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/diabetes.44.6.652","article-title":"A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group","volume":"44","author":"Hy\u00f6ty","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.antiviral.2009.11.003_bib24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/MMBR.28.4.382-390.1964","article-title":"Cellular susceptibility to enteroviruses","volume":"28","author":"Kunin","year":"1964","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.antiviral.2009.11.003_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/193097a0","article-title":"In vitro inhibition of infectivity of polio viruses by guanidine","volume":"193","author":"Loddo","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2009.11.003_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/AAC.29.1.30","article-title":"Oral efficacy of WIN 51711 in mice infected with human poliovirus","volume":"29","author":"McKinlay","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.11.003_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/AAC.27.1.102","article-title":"Controlled trial of enviroxime against natural rhinovirus infections in a community","volume":"27","author":"Miller","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.11.003_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2003.11.001","article-title":"Synergistic drug combinations against the in vitro replication of Coxsackie B1 virus","volume":"62","author":"Nikolaeva-Glomb","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.11.003_bib29","first-page":"73","article-title":"Antiviral effect of the combination of enviroxime and disoxaril on coxsackievirus B1 infection","volume":"44","author":"Nikolaeva","year":"2000","journal-title":"Acta Virol."},{"key":"10.1016\/j.antiviral.2009.11.003_bib30","first-page":"199","article-title":"A new highly potent antienteroviral compound","volume":"vol. I","author":"Nikolaeva-Glomb","year":"2008"},{"key":"10.1016\/j.antiviral.2009.11.003_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(03)00150-5","article-title":"Development of resistance to disoxaril in Coxsackie B1 virus-infected newborn mice","volume":"60","author":"Nikolova","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.11.003_bib32","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.11.003_bib33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2009.11.003_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0166-3542(89)90016-8","article-title":"The structure of antiviral agents that inhibit uncoating when complexed with viral capsids","volume":"11","author":"Rossmann","year":"1989","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.11.003_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/AEM.9.1.66-72.1961","article-title":"A plaque suppression method for the study of antiviral compounds","volume":"9","author":"Siminoff","year":"1961","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.antiviral.2009.11.003_bib36","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1126\/science.3018924","article-title":"The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating","volume":"233","author":"Smith","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2009.11.003_bib37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/247568a0","article-title":"Poikilothermia and susceptibility of suckling mice to Coxsackie B1 virus","volume":"247","author":"Teisner","year":"1974","journal-title":"Nature"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354209005130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354209005130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T15:59:15Z","timestamp":1590249555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354209005130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0166354209005130"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2009.11.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}